enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. A Potential Parkinson's Treatment Has Promising Results - AOL

   www.aol.com/potential-parkinsons-treatment...

   A small new trial published in the journal Nature Medicine describes what would be two firsts for Parkinson's disease, if they pan out: a diagnostic test and a potential immune-based treatment ...

3. FDA Approves AbbVie's Parkinson's Treatment, Medicare ... - AOL

   www.aol.com/fda-approves-abbvies-parkinsons...

   On Thursday, the FDA approved AbbVie Inc’s (NYSE:ABBV) Vyalev (foscarbidopa and foslevodopa) as the first and only subcutaneous 24-hour infusion of levodopa-based therapy for motor fluctuations ...

4. Hope for Parkinson’s disease symptoms is found in ... - AOL

   www.aol.com/finance/hope-parkinson-disease...

   A new drug has shown promise in alleviating symptoms. ... according to the Michael J. Fox Foundation for Parkinson’s Research. This causes tremors, slowness, stiffness, and walking and balance ...

5. Management of Parkinson's disease - Wikipedia

   en.wikipedia.org/wiki/Management_of_Parkinson's...

   In the management of Parkinson's disease, due to the chronic nature of Parkinson's disease (PD), a broad-based program is needed that includes patient and family education, support-group services, general wellness maintenance, exercise, and nutrition. At present, no cure for the disease is known, but medications or surgery can provide relief ...

6. Tavapadon - Wikipedia

   en.wikipedia.org/wiki/Tavapadon

   Tavapadon (developmental code names CVL-751, PF-06649751) is a dopamine receptor agonist which is under development for the treatment of Parkinson's disease. [2] [3] [4] It is under development by Cerevel Therapeutics, which acquired tavapadon from Pfizer in 2018. [2]

7. Research in Parkinson's disease - Wikipedia

   en.wikipedia.org/wiki/Research_in_Parkinson's...

   The research in Parkinson's disease (also known as clinical trials, medical research, research studies, or clinical studies) refers to any study intended to help answer questions about etiology, diagnostic approaches or new treatments of Parkinson's disease (PD) by studying their effects on human subjects.